Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ellipsys Vascular Access System Registry, Protocol 1.0. Version 1.0

NCT03454113 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03454113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ellipsys Vascular Access System Registry, Protocol 1.0. Version 1.0
Lead sponsor
Medtronic Endovascular
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
July 30, 2020
Enrollment
17 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease